1 Market Overview of β1 Adrenoceptor Agonists 1.1 β1 Adrenoceptor Agonists Market Overview 1.1.1 β1 Adrenoceptor Agonists Product Scope 1.1.2 β1 Adrenoceptor Agonists Market Status and Outlook 1.2 Global β1 Adrenoceptor Agonists Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global β1 Adrenoceptor Agonists Market Size by Region (2016-2027) 1.4 Global β1 Adrenoceptor Agonists Historic Market Size by Region (2016-2021) 1.5 Global β1 Adrenoceptor Agonists Market Size Forecast by Region (2022-2027) 1.6 Key Regions, β1 Adrenoceptor Agonists Market Size (2016-2027) 1.6.1 North America β1 Adrenoceptor Agonists Market Size (2016-2027) 1.6.2 Europe β1 Adrenoceptor Agonists Market Size (2016-2027) 1.6.3 Asia-Pacific β1 Adrenoceptor Agonists Market Size (2016-2027) 1.6.4 Latin America β1 Adrenoceptor Agonists Market Size (2016-2027) 1.6.5 Middle East & Africa β1 Adrenoceptor Agonists Market Size (2016-2027) 2 β1 Adrenoceptor Agonists Market Overview by Type 2.1 Global β1 Adrenoceptor Agonists Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global β1 Adrenoceptor Agonists Historic Market Size by Type (2016-2021) 2.3 Global β1 Adrenoceptor Agonists Forecasted Market Size by Type (2022-2027) 2.4 Dobutamine 2.5 Denopamine 2.6 Xamoterol 2.7 Others 3 β1 Adrenoceptor Agonists Market Overview by Application 3.1 Global β1 Adrenoceptor Agonists Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global β1 Adrenoceptor Agonists Historic Market Size by Application (2016-2021) 3.3 Global β1 Adrenoceptor Agonists Forecasted Market Size by Application (2022-2027) 3.4 Chronic Heart Failure 3.5 Myocardial Infarction 3.6 Postoperative Hypotension 3.7 Others 4 β1 Adrenoceptor Agonists Competition Analysis by Players 4.1 Global β1 Adrenoceptor Agonists Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in β1 Adrenoceptor Agonists as of 2020) 4.3 Date of Key Players Enter into β1 Adrenoceptor Agonists Market 4.4 Global Top Players β1 Adrenoceptor Agonists Headquarters and Area Served 4.5 Key Players β1 Adrenoceptor Agonists Product Solution and Service 4.6 Competitive Status 4.6.1 β1 Adrenoceptor Agonists Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Ivax Pharmaceuticals  5.1.1 Ivax Pharmaceuticals  Profile 5.1.2 Ivax Pharmaceuticals  Main Business 5.1.3 Ivax Pharmaceuticals  β1 Adrenoceptor Agonists Products, Services and Solutions 5.1.4 Ivax Pharmaceuticals  β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.1.5 Ivax Pharmaceuticals  Recent Developments 5.2 Physicians Total Care 5.2.1 Physicians Total Care Profile 5.2.2 Physicians Total Care Main Business 5.2.3 Physicians Total Care β1 Adrenoceptor Agonists Products, Services and Solutions 5.2.4 Physicians Total Care β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.2.5 Physicians Total Care Recent Developments 5.3 Baxter Healthcare  5.5.1 Baxter Healthcare  Profile 5.3.2 Baxter Healthcare  Main Business 5.3.3 Baxter Healthcare  β1 Adrenoceptor Agonists Products, Services and Solutions 5.3.4 Baxter Healthcare  β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.3.5 Sanofi Recent Developments 5.4 Sanofi 5.4.1 Sanofi Profile 5.4.2 Sanofi Main Business 5.4.3 Sanofi β1 Adrenoceptor Agonists Products, Services and Solutions 5.4.4 Sanofi β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.4.5 Sanofi Recent Developments 5.5 Teva Canada 5.5.1 Teva Canada Profile 5.5.2 Teva Canada Main Business 5.5.3 Teva Canada β1 Adrenoceptor Agonists Products, Services and Solutions 5.5.4 Teva Canada β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.5.5 Teva Canada Recent Developments 5.6 Pfizer 5.6.1 Pfizer Profile 5.6.2 Pfizer Main Business 5.6.3 Pfizer β1 Adrenoceptor Agonists Products, Services and Solutions 5.6.4 Pfizer β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.6.5 Pfizer Recent Developments 5.7 Bedford Laboratories 5.7.1 Bedford Laboratories Profile 5.7.2 Bedford Laboratories Main Business 5.7.3 Bedford Laboratories β1 Adrenoceptor Agonists Products, Services and Solutions 5.7.4 Bedford Laboratories β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.7.5 Bedford Laboratories Recent Developments 5.8 Novartis 5.8.1 Novartis Profile 5.8.2 Novartis Main Business 5.8.3 Novartis β1 Adrenoceptor Agonists Products, Services and Solutions 5.8.4 Novartis β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.8.5 Novartis Recent Developments 5.9 Sterimax 5.9.1 Sterimax Profile 5.9.2 Sterimax Main Business 5.9.3 Sterimax β1 Adrenoceptor Agonists Products, Services and Solutions 5.9.4 Sterimax β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.9.5 Sterimax Recent Developments 5.10 Teligent 5.10.1 Teligent Profile 5.10.2 Teligent Main Business 5.10.3 Teligent β1 Adrenoceptor Agonists Products, Services and Solutions 5.10.4 Teligent β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.10.5 Teligent Recent Developments 6 North America 6.1 North America β1 Adrenoceptor Agonists Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe β1 Adrenoceptor Agonists Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific β1 Adrenoceptor Agonists Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America β1 Adrenoceptor Agonists Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa β1 Adrenoceptor Agonists Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 β1 Adrenoceptor Agonists Market Dynamics 11.1 β1 Adrenoceptor Agonists Industry Trends 11.2 β1 Adrenoceptor Agonists Market Drivers 11.3 β1 Adrenoceptor Agonists Market Challenges 11.4 β1 Adrenoceptor Agonists Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market β1 Adrenoceptor Agonists Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global β1 Adrenoceptor Agonists Market Size by Region (2016-2021) & (US$ Million) Table 3. Global β1 Adrenoceptor Agonists Market Size Share by Region (2016-2021) Table 4. Global β1 Adrenoceptor Agonists Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global β1 Adrenoceptor Agonists Forecasted Market Size Share by Region (2022-2027) Table 6. Global β1 Adrenoceptor Agonists Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global β1 Adrenoceptor Agonists Market Size by Type (2016-2021) & (US$ Million) Table 8. Global β1 Adrenoceptor Agonists Revenue Market Share by Type (2016-2021) Table 9. Global β1 Adrenoceptor Agonists Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global β1 Adrenoceptor Agonists Revenue Market Share by Type (2022-2027) Table 11. Global β1 Adrenoceptor Agonists Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global β1 Adrenoceptor Agonists Market Size by Application (2016-2021) & (US$ Million) Table 13. Global β1 Adrenoceptor Agonists Revenue Market Share by Application (2016-2021) Table 14. Global β1 Adrenoceptor Agonists Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global β1 Adrenoceptor Agonists Revenue Market Share by Application (2022-2027) Table 16. Global β1 Adrenoceptor Agonists Revenue (US$ Million) by Players (2016-2021) Table 17. Global β1 Adrenoceptor Agonists Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in β1 Adrenoceptor Agonists as of 2020) Table 19. Date of Key Manufacturers Enter into β1 Adrenoceptor Agonists Market Table 20. Global β1 Adrenoceptor Agonists Top Players Headquarters and Area Served Table 21. β1 Adrenoceptor Agonists Product Solution and Service Table 22. Global β1 Adrenoceptor Agonists Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Ivax Pharmaceuticals  Basic Information List Table 25. Ivax Pharmaceuticals  Description and Business Overview Table 26. Ivax Pharmaceuticals  β1 Adrenoceptor Agonists Products, Services and Solutions Table 27. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Ivax Pharmaceuticals  (2016-2021) Table 28. Ivax Pharmaceuticals  Recent Developments Table 29. Physicians Total Care Basic Information List Table 30. Physicians Total Care Description and Business Overview Table 31. Physicians Total Care β1 Adrenoceptor Agonists Products, Services and Solutions Table 32. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Physicians Total Care (2016-2021) Table 33. Physicians Total Care Recent Developments Table 34. Baxter Healthcare  Basic Information List Table 35. Baxter Healthcare  Description and Business Overview Table 36. Baxter Healthcare  β1 Adrenoceptor Agonists Products, Services and Solutions Table 37. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Baxter Healthcare  (2016-2021) Table 38. Baxter Healthcare  Recent Developments Table 39. Sanofi Basic Information List Table 40. Sanofi Description and Business Overview Table 41. Sanofi β1 Adrenoceptor Agonists Products, Services and Solutions Table 42. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Sanofi (2016-2021) Table 43. Sanofi Recent Developments Table 44. Teva Canada Basic Information List Table 45. Teva Canada Description and Business Overview Table 46. Teva Canada β1 Adrenoceptor Agonists Products, Services and Solutions Table 47. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Teva Canada (2016-2021) Table 48. Teva Canada Recent Developments Table 49. Pfizer Basic Information List Table 50. Pfizer Description and Business Overview Table 51. Pfizer β1 Adrenoceptor Agonists Products, Services and Solutions Table 52. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Pfizer (2016-2021) Table 53. Pfizer Recent Developments Table 54. Bedford Laboratories Basic Information List Table 55. Bedford Laboratories Description and Business Overview Table 56. Bedford Laboratories β1 Adrenoceptor Agonists Products, Services and Solutions Table 57. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Bedford Laboratories (2016-2021) Table 58. Bedford Laboratories Recent Developments Table 59. Novartis Basic Information List Table 60. Novartis Description and Business Overview Table 61. Novartis β1 Adrenoceptor Agonists Products, Services and Solutions Table 62. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Novartis (2016-2021) Table 63. Novartis Recent Developments Table 64. Sterimax Basic Information List Table 65. Sterimax Description and Business Overview Table 66. Sterimax β1 Adrenoceptor Agonists Products, Services and Solutions Table 67. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Sterimax (2016-2021) Table 68. Sterimax Recent Developments Table 69. Teligent Basic Information List Table 70. Teligent Description and Business Overview Table 71. Teligent β1 Adrenoceptor Agonists Products, Services and Solutions Table 72. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Teligent (2016-2021) Table 73. Teligent Recent Developments Table 74. North America β1 Adrenoceptor Agonists Market Size by Country (2016-2021) & (US$ Million) Table 75. North America β1 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million) Table 76. Europe β1 Adrenoceptor Agonists Market Size by Country (2016-2021) & (US$ Million) Table 77. Europe β1 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million) Table 78. Asia-Pacific β1 Adrenoceptor Agonists Market Size by Region (2016-2021) & (US$ Million) Table 79. Asia-Pacific β1 Adrenoceptor Agonists Market Size by Region (2022-2027) & (US$ Million) Table 80. Asia-Pacific β1 Adrenoceptor Agonists Market Share by Region (2016-2021) Table 81. Asia-Pacific β1 Adrenoceptor Agonists Market Share by Region (2022-2027) Table 82. Latin America β1 Adrenoceptor Agonists Market Size by Country (2016-2021) & (US$ Million) Table 83. Latin America β1 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million) Table 84. Middle East & Africa β1 Adrenoceptor Agonists Market Size by Players (2016-2021) & (US$ Million) Table 85. Middle East & Africa β1 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million) Table 86. β1 Adrenoceptor Agonists Market Trends Table 87. β1 Adrenoceptor Agonists Market Drivers Table 88. β1 Adrenoceptor Agonists Market Challenges Table 89. β1 Adrenoceptor Agonists Market Restraints Table 90. Research Programs/Design for This Report Table 91. Key Data Information from Secondary Sources Table 92. Key Data Information from Primary Sources List of Figures Figure 1. Global β1 Adrenoceptor Agonists Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global β1 Adrenoceptor Agonists Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global β1 Adrenoceptor Agonists Market Share by Regions: 2021 VS 2027 Figure 4. Global β1 Adrenoceptor Agonists Forecasted Market Size Share by Region (2022-2027) Figure 5. North America β1 Adrenoceptor Agonists Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe β1 Adrenoceptor Agonists Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific β1 Adrenoceptor Agonists Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America β1 Adrenoceptor Agonists Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa β1 Adrenoceptor Agonists Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global β1 Adrenoceptor Agonists Market Size Share by Type in 2021 & 2027 Figure 11. Dobutamine Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Denopamine Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Xamoterol Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Global β1 Adrenoceptor Agonists Market Size Share by Application in 2021 & 2027 Figure 16. Chronic Heart Failure Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Myocardial Infarction Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Postoperative Hypotension Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. β1 Adrenoceptor Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Top 5 and Top 10 Players β1 Adrenoceptor Agonists Market Share in 2020 Figure 22. North America β1 Adrenoceptor Agonists Market Share by Country (2016-2027) Figure 23. United States β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 24. Canada β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 25. Germany β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 26. France β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 27. U.K. β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 28. Italy β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 29. Russia β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 30. Nordic β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 31. Rest of Europe β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 32. Asia-Pacific β1 Adrenoceptor Agonists Market Share by Region (2016-2027) Figure 33. China β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 34. Japan β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 35. South Korea β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 36. Southeast Asia β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 37. India β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 38. Australia β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 39. Rest of Asia-Pacific β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 40. Latin America β1 Adrenoceptor Agonists Market Share by Country (2016-2027) Figure 41. Mexico β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 42. Brazil β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 43. Rest of Latin America β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 44. Middle East & Africa β1 Adrenoceptor Agonists Market Share by Country (2016-2027) Figure 45. Turkey β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 46. Saudi Arabia β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 47. UAE β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 48. Rest of Middle East & Africa β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation

Ivax Pharmaceuticals  Physicians Total Care Baxter Healthcare  Sanofi Teva Canada Pfizer Bedford Laboratories Novartis Sterimax Teligent